CD4 and nasal cavity polyp: In order to evaluate the frequency of Foxp3+ Tregs in nasal polyps after rapamycin treatment, we examined CD4, CD25, and Foxp3 biomarkers in isolated cells from nasal polyps by flow cytometric analysis.